Placental growth factor for the prognosis of women with preeclampsia (fullPIERS model extension): context matters
Abstract Background The fullPIERS risk prediction model was developed to identify which women admitted with confirmed diagnosis of preeclampsia are at highest risk of developing serious maternal complications. The model discriminates well between women who develop (vs. those who do not) adverse mate...
Main Authors: | U. Vivian Ukah, Beth A. Payne, Jennifer A. Hutcheon, Lucy C. Chappell, Paul T. Seed, Frances Inez Conti-Ramsden, J. Mark Ansermino, Laura A. Magee, Peter von Dadelszen, for the fullPIERS Group |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | BMC Pregnancy and Childbirth |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12884-020-03332-w |
Similar Items
-
Insights into the pathogenesis of preeclampsia based on the features of placentation and tumorigenesis
by: Yun-Qing Zhu, et al.
Published: (2021-01-01) -
Expression of placental growth factor mRNA in preeclampsia
by: Pooneh Nikuei, et al.
Published: (2017-05-01) -
Sphingolipid Signature of Human Feto-Placental Vasculature in Preeclampsia
by: Ilaria Del Gaudio, et al.
Published: (2020-02-01) -
Dysregulation of Complement Activation and Placental Dysfunction: A Potential Target to Treat Preeclampsia?
by: E. Pierik, et al.
Published: (2020-01-01) -
Immune and Apoptosis Mechanisms Regulating Placental Development and Vascularization in Preeclampsia
by: Nozha Raguema, et al.
Published: (2020-02-01)